Dx dialogues: other potential treatments for indolent systemic mastocytosis

Dx dialogues: advancements in treating indolent systemic mastocytosis

Jan 14, 2026

Dx dialogues: diagnosing indolent systemic mastocytosis

Jan 14, 2026

Dx dialogues: helping physicians identify patients for combination therapies with CAR-T

Jan 14, 2026

Dx dialogues: post anti-CD38 therapy

Jan 14, 2026

Dx dialogues: common and emerging treatments for CRSwNP

Jan 14, 2026

DX dialogues: treating MASH

Jan 14, 2026

Dx dialogues: versatile treatment options across the multiple myeloma landscape

Jan 14, 2026

Dx dialogues: the importance of staying up to date with advancements in CRSwNP

Jan 14, 2026